Regulation - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

201 to 216 of 216 results

Australia's PIC reports to Ministers on treatment and reimbursement of similar biologics

14-06-2012

The Australian Pharmaceuticals Industry Council (PIC), with industry group members AusBiotech, Medicines…

Asia-PacificBiotechnologyGenericsPharmaceuticalPricingRegulation

Sanofi files for Japanese approval of diabetes drug Lyxumia

11-06-2012

French drug major Sanofi (Euronext: SAN), has submitted a marketing authorization application for lixisenatide…

Asia-PacificDiabeteslixisenatideLyxumiaPharmaceuticalRegulationSanofiZealand Pharma

Business in Japan versus to Japan, by P Reed Maurer

11-06-2012

A pharmaceutical company without a presence in Japan but with a hot new product ready for Phase III clinical…

Asia-PacificBiotechnologyMarkets & MarketingPharmaceuticalRegulation

NZ's PHARMAC consults on funding for Iressa and Tarceva

31-05-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, is seeking feedback on a proposal to:

Asia-PacificAstraZenecaIressaOncologyPharmaceuticalPricingRegulationRocheTarceva

Australia's TGA launches consultation on better medicines labeling

24-05-2012

Australia's medicine's regulator, the Therapeutic Goods Administration, has this week released a consultation…

Asia-PacificBiotechnologyGenericsPharmaceuticalRegulation

Impact of Japanese drug price reductions, by P Reed Maurer

10-05-2012

Outside observers have long predicted the mandated price reductions of drugs will kill the Japanese pharmaceutical…

Asia-PacificPharmaceuticalPricingRegulation

New Zealand considers listing of NovoMix 30 and NovoSeven RT and amendment for Glucagen Hypokit

02-05-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, is seeking feedback on a proposal to fund…

Asia-PacificDiabetesGlucaGenNovo NordiskNovoMixNovoSevenPharmaceuticalPricingRegulation

Arzerra and ospemifene NDAs submitted in Japan

02-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) and Danish company Genmab A/S (OMX: GEN) have submitted a…

ArzerraAsia-PacificGenmabGlaxoSmithKlineOncologyospemifenePharmaceuticalQuatRx PharmaRegulationShionogiWomen's Health

Indian government task force makes recommendations to curb drug counterfeiting

15-04-2012

Last week, a high-level task force on pharmaceutical manufacturing recommended the adoption of unique…

Asia-PacificPharmaceuticalRegulation

Actelion drops setipiprant, gets miglustat approval in Japan

04-04-2012

Switzerland-based Actelion Ltd (SIX: ATLN) announced says that it will re-direct its development efforts…

ActelionAsia-PacificBiotechnologyBrazavesInflammatory diseasesMiglustatRare diseasesRegulationResearchsetipiprantZavesca

Daiichi Sankyo files denosumab in Japan for osteoporosis

26-03-2012

Japanese drug major Daiichi Sankyo (TYO: 4568) revealed on Friday that it has filed for approval in Japan…

AmgenAnti-Arthritics/RheumaticsAsia-PacificDaiichi SankyodenosumabPharmaceuticalRegulation

New Zealand approves Effient listing for clopidogrel-allergic patients

19-03-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, has announced reaching agreement with US…

Asia-PacificCardio-vascularEffientEli LillyPharmaceuticalPricingRegulation

Sihuan Pharma heart drug IND accepted in China

12-03-2012

Leading China-based cardio-cerebral vascular drug firm Sihuan Pharmaceutical Holdings (HKEx: 0460) says…

Asia-PacificCardio-vascularMarkets & MarketingPharmaceuticalRegulationSihuan Pharmaceuticaltylerdipine

Australia latest to approve Bayer's Eylea

08-03-2012

The Australian Therapeutic Goods Administration (TGA) has approved Eylea (aflibercept) Injection for…

Asia-PacificBayerEyleaOphthalmicsPharmaceuticalRegeneronRegulation

201 to 216 of 216 results

Back to top